SRL
RCKT icon

Scientech Research LLC’s Rocket Pharmaceuticals RCKT Stock Holding History

Scientech Research LLC’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,079
Closed -$77.5K – 684
2025
Q4 		$77.5K Buy
+22,079
New +$75.6K 0.05% 423
2024
Q2 		– Sell
-15,858
Closed -$427K – 716
2024
Q1 		$427K Buy
15,858
+8,777
+124% +$249K 0.23% 203
2023
Q4 		$212K Buy
+7,081
New +$156K 0.21% 239

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Scientech Research LLC's RCKT Position: Q1 2026 in Review

Scientech Research LLC sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 22,079 shares — an estimated $77.5K sold.

Scientech Research LLC first reported a position in RCKT in Q4 2023 and held it in 3 quarters. The position peaked at $427K in Q1 2024. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Scientech Research LLC reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Scientech Research LLC sold 22,079 Rocket Pharmaceuticals shares in Q1 2026, an estimated $77.5K.
  • Scientech Research LLC first reported a position in Rocket Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • Scientech Research LLC's Rocket Pharmaceuticals position peaked at $427K in Q1 2024.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.